<code id='DE68130405'></code><style id='DE68130405'></style>
    • <acronym id='DE68130405'></acronym>
      <center id='DE68130405'><center id='DE68130405'><tfoot id='DE68130405'></tfoot></center><abbr id='DE68130405'><dir id='DE68130405'><tfoot id='DE68130405'></tfoot><noframes id='DE68130405'>

    • <optgroup id='DE68130405'><strike id='DE68130405'><sup id='DE68130405'></sup></strike><code id='DE68130405'></code></optgroup>
        1. <b id='DE68130405'><label id='DE68130405'><select id='DE68130405'><dt id='DE68130405'><span id='DE68130405'></span></dt></select></label></b><u id='DE68130405'></u>
          <i id='DE68130405'><strike id='DE68130405'><tt id='DE68130405'><pre id='DE68130405'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:comprehensive    Page View:1832
          A Eye
          Alex Hogan/STAT

          Apellis Pharmaceuticals said Tuesday that it had identified “internal structural variations” in a type of needle used by doctors to prepare syringes of its eye disease drug Syfovre as a possible cause of severe eye inflammation reported in patients receiving the treatment — but the company stopped short of definitively linking the needle to the cases.

          Additionally, Apellis confirmed one additional case of the severe and potentially blinding side effect, known as retinal occlusive vasculitis, or ROV, that occurred in May. But with thousands of more Syfovre eye injections also performed, the overall frequency of ROV remains unchanged and rare, even with the added scrutiny and increased physician monitoring.

          advertisement

          Apellis shares rose 30% to $40 in Wednesday’s pre-market trading on the growing belief amongst investors that Syfovre’s safety crisis is abating.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Biden outlines 'new path' to provide student loan relief after Supreme Court rejection
          Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

          6:16PresidentJoeBidenspeaksintheRooseveltRoomoftheWhiteHouse,June30,2023.EvanVucci/APPresidentJoeBid

          read more
          Why did Pfizer dish out millions for a Super Bowl ad?
          Why did Pfizer dish out millions for a Super Bowl ad?

          Pfizer'sSuperBowladshowedcompanyfoundersCharlesPfizerandCharlesErhartsingingQueen’s“Don’tStopMeNow"a

          read more
          Dobbs anniversary: the lost opportunity of abortion as health care
          Dobbs anniversary: the lost opportunity of abortion as health care

          NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

          read more

          Readout LOUD podcast: How biotech is using artificial intelligence

          HasAIreallysolvedbiology?Whatcanmachinesteachusaboutmedicine?Andwhat’sadigitaltwin?Wecoverallthatand